Compound class:
Synthetic organic
Comment: NF770 is a P2X2 receptor antagonist [1]. Note that we show the salt (Na) stripped structure, but strictly NF770 is the tetra sodium salt shown in PubChem CID 53310473. This structure matches example 8b in patent US20130338178 [3] claiming suramin derivatives as sirtuin modulators.
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
References |
1. Jacobson KA, Müller CE. (2016)
Medicinal chemistry of adenosine, P2Y and P2X receptors. Neuropharmacology, 104: 31-49. [PMID:26686393] |
2. North RA, Jarvis MF. (2013)
P2X receptors as drug targets. Mol Pharmacol, 83 (4): 759-69. [PMID:23253448] |
3. Shenk T, Koyuncu E, Cristea I. (2013)
Sirtuin modulators as inhibitors of cytomegalovirus. Patent number: US20130338178. Assignee: The Trustees Of Princeton University. Priority date: 20/02/2011. Publication date: 19/12/2013. |